Hutchison China Meditech Limited Director's Share Dealing (6317G)

TIDMHCM

RNS Number : 6317G

Hutchison China Meditech Limited

09 August 2016

Director's Share Dealing

London: Tuesday, August 9, 2016: Hutchison China MediTech Limited ("Chi-Med") (AIM/Nasdaq: HCM) has received notification that the spouse of Mr Christopher Nash, Independent Non-executive Director, has purchased 3,120 and 42 ordinary shares of US$1.00 each in Chi-Med (the "Ordinary Shares") at a price of GBP19.00 and GBP18.99 per share respectively on August 4, 2016.

Following the above transaction, the combined holding of Mr Nash and his spouse is 39,596 Ordinary Shares, representing approximately 0.065% of the current issued share capital of Chi-Med.

The notification set out below is provided in accordance with the requirements of the EU Market Abuse Regulation.

 
 1     Details of the person discharging managerial responsibilities/person closely associated 
----  ---------------------------------------------------------------------------------------------------------------- 
  a)    Name                                                     Ms Rebecca Pynt 
----  -------------------------------------------------------  ------------------------------------------------------- 
 2     Reason for the notification 
----  ---------------------------------------------------------------------------------------------------------------- 
  a)    Position/status                                          Spouse of Mr Christopher Nash, an Independent 
                                                                 Non-executive Director of Chi-Med 
----  -------------------------------------------------------  ------------------------------------------------------- 
  b)    Initial notification/Amendment                           Initial notification 
----  -------------------------------------------------------  ------------------------------------------------------- 
 3     Details of the issuer, emission allowance market participant, auction platform, auctioneer 
        or auction monitor 
----  ---------------------------------------------------------------------------------------------------------------- 
  a)    Name                                                     Hutchison China MediTech Limited 
----  -------------------------------------------------------  ------------------------------------------------------- 
  b)    LEI                                                      N/A 
----  -------------------------------------------------------  ------------------------------------------------------- 
 4     Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) 
        each type of transaction; (iii) each date; and (iv) each place where transactions have been 
        conducted 
----  ---------------------------------------------------------------------------------------------------------------- 
  a)    Description of the financial instrument, type of         Ordinary Shares of US$1.00 each 
        instrument                                                DI ISIN: KYG4672N1016 
        Identification code                                       ADS ISIN: US44842L1035 
----  -------------------------------------------------------  ------------------------------------------------------- 
  b)    Nature of the transaction                                Acquisition of 3,120 and 42 Ordinary Shares on August 
                                                                 4, 2016 at a price of GBP19.00 and GBP18.99 
                                                                 respectively 
----  -------------------------------------------------------  ------------------------------------------------------- 
  c)    Price(s) and volume(s)                                    Price(s)    Volume(s) 
                                                                  ----------  ---------- 
                                                                   GBP19.00      3,120 
                                                                  ----------  ---------- 
                                                                   GBP18.99       42 
                                                                  ----------  ---------- 
----  -------------------------------------------------------  ------------------------------------------------------- 
  d)    Aggregated information                                   N/A 
         -  Aggregated volume 
         -  Price 
----  -------------------------------------------------------  ------------------------------------------------------- 
  e)    Date of the transaction                                  2016-08-04 
----  -------------------------------------------------------  ------------------------------------------------------- 
  f)    Place of the transaction                                 London Stock Exchange (XLON) 
----  -------------------------------------------------------  ------------------------------------------------------- 
 

NOTES TO EDITORS

About Chi-Med

Chi-Med is an innovative China-based biopharmaceutical company which researches, develops, manufactures and sells pharmaceuticals and healthcare products. Its Innovation Platform, Hutchison MediPharma Limited, focuses on discovering and developing innovative therapeutics in oncology and autoimmune diseases for the global market. Its Commercial Platform manufactures, markets, and distributes prescription drugs and consumer health products in China.

Chi-Med is majority owned by the multinational conglomerate CK Hutchison Holdings Limited (SEHK: 0001). For more information, please visit: www.chi-med.com.

Contacts

 
Investor Enquiries 
Christian Hogg, CEO               [phone] 
 
International Media Enquiries 
Anthony Carlisle,                 [phone] (Mobile)   [e-mail] 
 Citigate Dewe Rogerson 
 
U.S. Based Media Enquiries 
Brad Miles, BMC Communications    [phone] (Mobile)  [e-mail] 
 
Susan Duffy, BMC Communications   [phone] (Mobile)  [e-mail] 
 
Investor Relations 
Brian Korb, The Trout Group       [phone] (Mobile)  [e-mail] 
 
David Dible,                      [phone] (Mobile)   [e-mail] 
 Citigate Dewe Rogerson 
 
Panmure Gordon (UK) Limited 
Richard Gray / Andrew Potts       [phone] 
 

This information is provided by RNS

The company news service from the London Stock Exchange

END

DSHLIFIDTRIAIIR

(END) Dow Jones Newswires

August 09, 2016 03:07 ET (07:07 GMT)